We facilitate cooperation among funding organizations that invest in research to improve pandemic preparedness & response.Our working groups Focus on COVID-19
GloPID-R brings together funders investing in research related to new or re-emerging infectious diseases. Our aim is to increase preparedness and speed up the research response to outbreaks with pandemic potential.
Through our working groups, we identify gaps and areas of duplication to ensure that investment in priority research areas is balanced and coordinated, with a focus on lower resourced settings. Our work aims to support R&D to generate knowledge and solutions that will save lives.
Improving the way funders work together is essential so that the world will be better prepared for the next infectious disease outbreak. The COVID-19 pandemic has taught us that none of us is safe until all of us are safe.Read more
GloPID-R coordinates the work of funders to ensure a timely, effective research response to infectious disease outbreaks with epidemic and pandemic potential. We map emerging research trends, determine critical research priorities, and seek solutions to address knowledge gaps.COVID-19 timeline
In addition to GloPID-R’s 33 member funding organizations, WHO, CEPI, EDCTP, ERINHA, ESSENCE on Health Research, GAVI and GOARN are also actively engaged in the network as observers.All members
National Institute of Health, Department of Medical Sciences
Represented by Aree Thattiyaphong
Coalition for Epidemic Preparedness Innovations (CEPI)
Represented by Richard Hatchett & Frederik Kristensen
National Research and Innovation Fund for Development (FONRID)
Represented by Hamidou H. Tamboura
Netherlands Organisation for Health research and Development (ZonMw)
Represented by Suzanne Verver
European & Developing Countries Clinical Trials Partnership (EDCTP)
Represented by Pauline Beattie
German Federal Ministry of Education and Research (BMBF) / DLR-PT
Dr. Christina Müller
Research & Reports
Webinars & Videos
The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874667.